Global Poultry Vaccines Market Analysis On The Basis Of Application, Product, Disease Type, And Region

raghurajgvr

Apr 21

Poultry Vaccines Industry Overview

The global poultry vaccines market size is expected to reach USD 3.3 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.40% from 2023 to 2030. The key factors driving the market include the rising consumption of poultry meat and eggs, the prevalence of avian diseases, and the increasing poultry population in key markets. According to OECD-FAO Agricultural Outlook, poultry meat consumption in the U.S. was pegged at 19,169 thousand tons in 2020. This consumption is projected to increase over the next few years.

The COVID-19 pandemic resulted in several challenges for the poultry industry including a fall in consumption, increased concerns over zoonoses, and low sales. For example, as per the Economic Times, in March 2020, the price of chicken plunged by as much as 70% due to the reduced consumption of meat, fish, eggs, and chicken. However, the pandemic also led to the rising awareness regarding diseases in animals and increasing demand for safe and healthy poultry products. This is anticipated to create opportunities for poultry vaccines manufacturers as poultry farms must ensure healthy layer, broiler, and breeder stock. In fact, in April 2021, the CEO & MD of Hester Biosciences Ltd. stated that the market for poultry vaccines is set to grow significantly post COVID.

In addition, the advent of new vaccines, such as Salmonella-vectored vaccines, which protect domesticated birds against necrotic enteritis is anticipated to provide a growth platform to this market. In addition, the rising usage of poultry vaccines by research institutes and colleges, along with vaccination awareness programs, is fueling the growth of the market. For instance, in July 2019, the Veterinary College and Research Institute based in Madurai, India started vaccinating domesticated birds, predominantly chickens, to save farmers from suffering significant losses.

Technological advancements in poultry vaccines, rising demand for animal protein, concerns over food safety, animal welfare, and microbial resistance, increased focus on avian healthcare, and shift from treatment to the prevention of diseases are some of the other factors anticipated to create growth opportunities in the market. For instance, the TAbic Vaccines Line by Phibro Animal Health Corporation comprises 25+ vaccines for poultry for protection against Newcastle disease, infectious bronchitis, and other poultry diseases.

Poultry Vaccines Market Segmentation

Grand View Research has segmented the global poultry vaccines market on the basis of application, product, disease type, and region:

Based on the Application, the market is segmented into Broiler, Layer, and Breeder.

The breeder segment held the largest revenue share of over 35.0% in 2022. The breeder segment is expected to exhibit the fastest growth rate during the forecast period owing to the increasing number of breeder farms producing fertile eggs, which are hatched in a hatchery.
The policy aimed to enhance the production from layers and commercial broilers and encourage the processing of eggs and chickens, thereby promoting export activities. Such favorable initiatives by the government are further driving the market.

Based on the Product, the market is segmented into Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, and Recombinant Vaccines.

The attenuated live vaccines segment held the largest revenue share of over 30.0% in 2022. These types of vaccines can trigger the immune system to produce a greater number of antibodies as compared to other types of vaccines.
The recombinant vaccines and inactivated vaccines are one of the fastest growing segments in the coming years. The key factors contributing to this growth include product developments and safety benefits associated with inactivated and recombinant vaccines in comparison to live attenuated vaccines.

Based on the Disease Type, the market is segmented into Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus, Duck Viral Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, and Fowl Cholera.

The salmonella diseases segment accounted for the largest revenue share of over 8.0% in 2022. The Egg Drop Syndrome (EDS) segment is expected to expand at the fastest CAGR over the forecast period. This is owing to the high prevalence of Salmonella and Egg Drop Syndrome diseases in poultry animals.
The most common type of vaccine for salmonella is the attenuated Salmonella strains, which can serve as effective as well as safe oral carrier vaccines for preventing necrotic enteritis by expressing heterologous antigens.

Key Companies & Market Share Insights

The market has been characterized by immense competition owing to the presence of local and global players trying to increase their penetration via different strategic moves such as new product development, M&A, JV, partnerships, and distribution channel agreements. For instance, in July 2019, Ceva acquired IDT Biologika GmbH's veterinary biopharmaceutical as well as R&D business. Additionally, Boehringer Ingelheim launched the VAXXITEK HVT+IBD+ND vaccine in January 2020, to protect poultry against Newcastle Disease, Marek's Disease, and Infectious Bursal Disease (classic and variant types). Some prominent players in the global poultry vaccines market include:

Boehringer Ingelheim International GmbH
Ceva
Zoetis
Elanco
Merck & Co., Inc.
Hester Biosciences Limited
Vaxxinova International BV
Venkys India
Calier
KM Biologics
Phibro Animal Health Corporation

Order a free sample PDF of the Poultry Vaccines Market Intelligence Study, published by Grand View Research.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Comment